MoneyWorks4Me

The Revenue for the quarter ended  June 2023 of Rs. 853.49 millions grew by 18.36 % from Rs. 721.10 millions.The Total revenue for the quarter ended June 2023 of  Rs. 674.87  millions  grew by 767.67% from Rs. 77.78 millions.The company reported a good operating profit of 760.26 millions compared to 127.13 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 853.49 721.10 18.36 853.49 721.10 18.36 3115.29 2727.98 14.20
Other Income 512.49 12.45 4016.39 512.49 12.45 4016.39 98.08 90.80 8.02
PBIDT 760.26 127.13 498.02 760.26 127.13 498.02 846.96 817.28 3.63
Interest 0.35 0.28 25.00 0.35 0.28 25.00 1.35 0.95 42.11
PBDT 759.91 126.85 499.06 759.91 126.85 499.06 845.61 816.33 3.59
Depreciation 25.07 24.09 4.07 25.07 24.09 4.07 102.83 95.61 7.55
PBT 734.84 102.76 615.10 734.84 102.76 615.10 742.78 720.72 3.06
TAX 59.97 24.98 140.07 59.97 24.98 140.07 187.51 175.61 6.78
Deferred Tax -0.68 -1.08 -37.04 -0.68 -1.08 -37.04 4.97 -4.56 -208.99
PAT 674.87 77.78 767.67 674.87 77.78 767.67 555.27 545.11 1.86
Equity 223.65 223.61 0.02 223.65 223.61 0.02 223.65 223.60 0.02
PBIDTM(%) 89.08 17.63 405.26 89.08 17.63 405.26 27.19 29.96 -9.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..